Exciting Findings from Dr. Phideas Diamandis
Findings from a new study led by MBP researcher Dr. Phideas Diamandis could help physicians identify aggressive cancers, leading to enhanced customized treatments for individual patients.
The study, titled Proteomic analysis of meningiomas reveals clinically-distinct molecular patterns, suggests that protein patterns expressed by brain tumours reveal information about their aggressiveness and location, information that can be useful in disease management.
To achieve these results, Dr. Diamandis and his team used state-of-the-art technology to profile over 3,000 proteins in 61 meningioma tumours, comparing protein patterns across different groups of cancers based on the aggressiveness, location, treatment type and instances of post-treatment recurrance.